Boston Scientific Corporation (BSX) Institutional Ownership & Insider Trading

1,474 institutions reported holding Boston Scientific Corporation shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings. 21 insider trades on Form 4 since 2025-10-01.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

BSXBoston Scientific CorporationFollow BSX — free

Medical Devices · Healthcare

—

Price chart with a free account

Market cap: 66.2B
P/E TTM: 18.5
Dividend yield: —
52-week: —
Next earnings: 28 Oct, in 4 days

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

1,474 institutions held 92.1% of the shares. Across filers that reported both quarters, shares held changed -2.6%.

Largest moves, shares (millions)

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters

Quarter	Holders	Shares held, M	Change	Increased	New	Decreased	Closed
Jun 26	1,474	1335	-2.6%	545	107	580	290
Mar 26	1,646	1340	+0.2%	609	126	565	237
Dec 25	1,744	1356	-2.7%	577	100	579	98
Sep 25	1,668	1366	+2.6%	656	129	451	103
Jun 25	1,654	1347	+0.2%	643	106	452	63
Mar 25	1,594	1319	+0.4%	581	175	467	46
Dec 24	1,461	1334	-1.2%	518	94	414	62
Sep 24	1,355	1301	-2.3%	467	120	385	54

Boston Scientific Corporation — questions

Who owns Boston Scientific Corporation stock?: 1,474 institutions reported Boston Scientific Corporation shares in 13F filings for the quarter ended 2026-06-30. The largest: BlackRock, Inc. (8.9%), VANGUARD CAPITAL MANAGEMENT LLC (6.7%), STATE STREET CORP (4.8%).
Are Boston Scientific Corporation insiders buying or selling?: 21 insider trades on Form 4 since 2025-10-01; the full list, with dates, people and plan status, is on this page.

Every figure on this page comes from Boston Scientific Corporation's own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.

Important information. Figures on this page are taken from filings submitted to the U.S. Securities and Exchange Commission (SEC) and processed automatically by EquiReason. They may contain errors, omissions or delays, and EquiReason makes no representation or warranty as to their accuracy, completeness or timeliness. Always verify figures against the original filing on SEC EDGAR before relying on them.

This page is provided for general information and educational purposes only. It does not constitute investment, financial, legal or tax advice, and it is not a recommendation or an offer to buy, sell or hold any security. It does not take into account your objectives, financial situation or needs. Past performance does not guarantee future results; any reliance on this information is at your own risk. See our Disclaimer and Risk Disclosure.